Immunofluorescence Analyzer Market, By Product Type (Chemiluminescence (CLI) Analyzers, Immuno Fluorescence (IFA) Analyzers, Enzyme Immunoassay Instruments, Radioimmunoassay Analyzers, Enzyme Linked Fluorescent Systems, and Multiplexed Assay Systems), By Application (Cancer, Endocrinology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Therapeutic Drug Monitoring, and Others), By End User (Hospital, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Others) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI12419 | Publish Date: April 2024 | No. of Pages: 180

Global Immunofluorescence Analyzer Market By Overview

Introduction:

Immunofluorescence Analyzer Market accounted for US$ 2.4 Billion in 2024 and is estimated to be US$ 4.4 Billion by 2034 and is anticipated to register a CAGR of 41.70%.

Immunofluorescence is light microscopy technique that involves a fluorescence microscope and usually applied to microbiological samples. It allows visualization of molecules through the samples. This is based on use of specific antibodies which have been chemically conjugated to fluorescent dyes.

Global immunofluorescence analyzer market is expected to show a good growth over the forecast period owing to launches of novel products by key players in the market. For instance, in March 2018, Quidel Corporation received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Sofia Lyme FIA to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid differential detection of human IgM and IgG antibodies to Borreliaburgdorferi from serum and plasma specimens from patients suspected of B. burgdorferi infection. 

Furthermore, rising prevalence of chronic disorders is also expected to rise demand for novel diagnosis methods such as immunofluorescence analyzer for the diagnosis of these disease which in turn is expected to drive global immunofluorescence analyzer market growth in near future. For instance, As per National Cancer Institute estimations it is expected that in 2018, around 1,735,350 new cases of cancer will be diagnosed in the U.S. and about 609,640 people will die from the disease.

As per World Health Organization, 17.9Mn people die each year from cardiovascular diseases CVDs, an estimated 31% of all deaths worldwide.

Immunofluorescence analyzer market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the global immunofluorescence analyzer market has been segmented in chemiluminescence (CLI) analyzers, immuno fluorescence (IFA) analyzers, enzyme immunoassay instruments, radioimmunoassay analyzers, enzyme linked fluorescent systems, and multiplexed assay systems.

On the basis of application, the immunofluorescence analyzer market has been segmented in cancer, endocrinology, infectious diseases, cardiovascular diseases, autoimmune diseases, therapeutic drug monitoring, and others.

On the basis of end user, the immunofluorescence analyzer market has been segmented in hospital, diagnostic laboratories, pharmaceutical & biotechnology companies, and others.

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the immunofluorescence analyzer market includes, Thermo Fisher Scientific, bioMerieux S.A., Abbott Laboratories, Siemens Healthcare, EMD Millipore,  DiaSorin S.p.A., Roche Diagnostics, and Bio-Rad: Company.

Global Immunofluorescence Analyzer Market By Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Immunofluorescence Analyzer Market, By Product Type, Forecast Period up to 10 Years, (US$ Mn)

  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Chemiluminescence (CLI) Analyzers
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Immuno Fluorescence (IFA) Analyzers
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Enzyme Immunoassay Instruments
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Radioimmunoassay Analyzers
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Enzyme Linked Fluorescent Systems
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Multiplexed Assay Systems
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Immunofluorescence Analyzer Market, By Application, Forecast Period up to 10 Years, (US$ Mn)

  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Cancer
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Endocrinology
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Infectious Diseases
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cardiovascular Diseases
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Autoimmune Diseases
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Therapeutic Drug Monitoring
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Immunofluorescence Analyzer Market, By End User, Forecast Period up to 10 Years, (US$ Mn)

  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Hospital
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Diagnostic Laboratories
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Pharmaceutical
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Biotechnology Companies
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Immunofluorescence Analyzer Market, By Region, Forecast Period up to 10 Years, (US$ Mn)

  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Mn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Mn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Mn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Mn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Distribution Channel, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Mn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • Thermo Fisher Scientific.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • BioMerieux S.A
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Siemens Healthcare
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • EMD Millipore
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • DiaSorin S.p.A.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Roche Diagnostics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bio-Rad: Company
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

Immunofluorescence Analyzer Market is segmented into on the basis of product type, application, and end user.

Factors driving the Immunofluorescence Analyzer Market include increasing prevalence of infectious diseases and chronic conditions, advancements in diagnostic technologies, growing demand for automated and rapid testing methods, and rising investments in healthcare infrastructure.

Restraints of the Immunofluorescence Analyzer Market include high costs associated with equipment and reagents, limited accessibility in developing regions, challenges in standardization and interpretation of results, and regulatory hurdles in approval processes.

By region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is estimated to witness a significantly high revenue share over the forecast period.

The key players operating the target market includes, Thermo Fisher Scientific, bioMerieux S.A., Abbott Laboratories, Siemens Healthcare, EMD Millipore, DiaSorin S.p.A., Roche Diagnostics, and Bio-Rad: Company.